Issue Date | Title | Author(s) |
2016-11-01 | Anticholinergic Drug Burden in Noncancer Versus Cancer Patients Near the End of Life | Hochman, MJ; Kamal, AH; Wolf, SP; Samsa, GP; Currow, DC; Abernethy, AP; LeBlanc, TW |
2019-05-01 | Anticholinergic Drug Burden in Noncancer Versus Cancer Patients Near the End of Life (vol 52, pg 737, 2016) | Hochman, MJ; Kamal, AH; Wolf, SP; Samsa, GP; Currow, DC; Abernethy, AP; LeBlanc, TW |
2012-12-01 | Considerations in reporting palliative care clinical trials: Standardizing information reported and authorship practices | LeBlanc, TW; Abernethy, AP; Currow, DC; Kutner, JS |
2018-05-01 | It is time to rethink weight loss in cancer | Currow, DC; LeBlanc, TW |
2014 | Management of dyspnea | LeBlanc, TW; Currow, D; Phillips, JL; Abernethy, AP; Quill, TE; Miller, FG |
2013-01-01 | Overcoming recruitment challenges in palliative care clinical trials | LeBlanc, TW; Lodato, JE; Currow, DC; Abernethy, AP |
2015-01-01 | Polypharmacy in patients with advanced cancer and the role of medication discontinuation | LeBlanc, TW; McNeil, MJ; Kamal, AH; Currow, DC; Abernethy, AP |
2017-10-01 | The Prospective Evaluation of the Net Effect of Red Blood Cell Transfusions in Routine Provision of Palliative Care | To, THM; LeBlanc, TW; Eastman, P; Neoh, K; Agar, MR; To, LB; Rowett, D; Vandersman, Z; Currow, DC |
2015-05-01 | Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness a randomized clinical trial | Kutner, JS; Blatchford, PJ; Taylor, DH; Ritchie, CS; Bull, JH; Fairclough, DL; Hanson, LC; LeBlanc, TW; Samsa, GP; Wolf, S; Aziz, NM; Currow, DC; Ferrell, B; Wagner-Johnston, N; Zafar, SY; Cleary, JF; Dev, S; Goode, PS; Kamal, AH; Kassner, C; Kvale, EA; McCallum, JG; Ogunseitan, AB; Pantilat, SZ; Portenoy, RK; Prince-Paul, M; Sloan, JA; Swetz, KM; Von Gunten, CF; Abernethy, AP |